1993 US Medical Inflation "Lowest In Seven Years"

5 December 1994

Medical inflation in the USA in 1993 was the lowest in seven years and among the lowest in more than three decades, according to the US Health Care Financing Administration. Average per capita spending was $3,299, up $205 on the previous year.

The national health bill was $884 billion, 7.8% more than 1992, the slowest rate of rise since 1986 and the third lowest since 1960. Health care's share of Gross Domestic Product rose to 13.9% from 13.6%, and Americans spent almost $1 of every $7 they make on health care, much more than people living elsewhere, it was noted.

Health and Human services Secretary Donna Shalala said the expenditures rose 2.4% faster than the overall economy in 1993, as measured by GDP, and HCFA administrator Bruce Vladek noted that the slowdown represents low inflation in the overall economy, more than anything else.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight